Skip Navigation
National Cancer Institute
Cancer Control & Population Sciences Home - NCI's Bridge to Public Health Research, Practice and Policy

Cancer Control Research

5R44CA088557-03
Mcfarren, Ann E.
RECURRENT PROSTATE CANCER: A DECISION SUPPORT GUIDE

Abstract

DESCRIPTION (provided by applicant): An estimated 50-75% of men undergoing surgery or radiation treatment for prostate cancer will experience signs of recurrence within 10 years, prompting additional treatment decisions. The proposed Recurrent Prostate Cancer: Your Decision Notebook TM CD-ROM will provide information and interactive tools to focus patient learning and promote informed treatment decision-making. HealthMark completed the Phase I project aims, demonstrating the feasibility of producing a multimedia tool that improves patients' knowledge and increases self-efficacy of treatment decision-making processes. In Phase II, HealthMark will produce the remainder of the product's information and interactive decision-support tools. A National Medical Review Board will review the CD-ROM for accuracy and patient appropriateness. A two-group randomized field test will assess the programs' effectiveness at changing patients' knowledge, decision self-efficacy and decision satisfaction, while decreasing decision uncertainty.


NIH…Turning Discovery Into Health
National Cancer Institute U.S. National Institutes of Health National Cancer Institute